ONCOR CONCLUDES PUBLIC OFFERING
ONCOR CONCLUDES PUBLIC OFFERING GAITHERSBURG, Md., Feb. 7 /PRNewswire/ -- Oncor, Inc.
(NASDAQ: ONCR), today announced that it has completed a public offering of 3,450,000 common shares, including the underwriters 100 percent exercise of its over-allotment option of 450,000 shares, at a price to the public of $10.50 per share with total net proceeds to Oncor of approximately $33,706,500, before deducting estimated offering expenses.
Smith Barney, Harris Upham & Co. Incorporated and Vector Securities International Inc. are the representatives of the several underwriters that offered the shares to the public. Proceeds from the sale of the shares by Oncor are expected to be used for product research and development, capital expenditures, sales and marketing and general corporate and working capital purposes. Oncor develops, manufactures and markets DNA probe test systems and related products for use in the diagnosis, monitoring and management of cancer and other genetic diseases. -0- 2/7/92 /CONTACT: Stephen Turner chairman & CEO of Oncor, Inc., 301-963-3500/ (ONCR) CO: Oncor, Inc. ST: Maryland IN: MTC SU: OFR
SB-KW -- NY069 -- 7900 02/07/92 15:59 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 7, 1992|
|Previous Article:||GUILTY PLEA IN PUERTO RICO HIJACKING CASE|
|Next Article:||MITSUBISHI MOTORS NAMES LEPLEY SENIOR VICE PRESIDENT/SALES AND MARKETING AS COMPANY ANNOUNCES NEW REORGANIZATIONAL STRUCTURE|